Literature DB >> 8370292

Regional blood flow and oxygen transport in septic shock.

E Ruokonen1, J Takala, A Kari, H Saxén, J Mertsola, E J Hansen.   

Abstract

OBJECTIVE: To measure the blood flow distribution and regional oxygen transport in hyperdynamic septic shock during hypotension and after correction by vasopressor doses of dopamine or norepinephrine.
DESIGN: Prospective, randomized, controlled trial.
SETTING: Tertiary care center. PATIENTS: Ten patients with hyperdynamic septic shock (ages ranging from 45.1 +/- 16.6 yrs) and a control group of 11 postoperative cardiac surgery patients (ages ranging from 54.8 +/- 7.9 yrs).
INTERVENTIONS: Systemic and regional hemodynamics and oxygen transport were measured in ten patients with hyperdynamic septic shock during hypotension and after vasopressor therapy (norepinephrine or dopamine). Oxygen consumption (VO2) was measured by indirect calorimetry and splanchnic and leg blood flow with indocyanine green infusion.
MEASUREMENTS AND MAIN RESULTS: Splanchnic blood flow and VO2 (p < .05) were increased in septic shock during hypotension and during vasopressor therapy. Both dopamine and norepinephrine increased systemic blood flow and VO2 independently of the arterial lactate level. Despite the relatively small changes in systemic oxygen transport, major regional changes occurred in oxygen delivery and VO2, and these changes were unpredictable from systemic changes.
CONCLUSIONS: Regional changes in oxygen transport in septic shock cannot be predicted from the changes in the whole body. The increased oxygen demand in the splanchnic region is the main risk factor for splanchnic tissue hypoxia in septic shock.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370292     DOI: 10.1097/00003246-199309000-00011

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  40 in total

1.  Splanchnic haemodynamic disturbances in perinatal sepsis.

Authors:  S T Kempley; E Murdoch
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-09       Impact factor: 5.747

2.  Aerosolized prostacyclin and inhaled nitric oxide in septic shock--different effects on splanchnic oxygenation?

Authors:  O Eichelbrönner; H Reinelt; H Wiedeck; M Mezödy; R Rossaint; M Georgieff; P Radermacher
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

Review 3.  Monitoring the hepato-splanchnic region in the critically ill patient. Measurement techniques and clinical relevance.

Authors:  A Brinkmann; E Calzia; K Träger; P Radermacher
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

Review 4.  Fluid balance and acute kidney injury.

Authors:  John R Prowle; Jorge E Echeverri; E Valentina Ligabo; Claudio Ronco; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2009-12-22       Impact factor: 28.314

Review 5.  Tissue hypoxia. How to detect, how to correct, how to prevent?

Authors:  C Richard
Journal:  Intensive Care Med       Date:  1996-11       Impact factor: 17.440

Review 6.  Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.

Authors:  Peter De Paepe; Frans M Belpaire; Walter A Buylaert
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

7.  Splanchnic perfusion in shock.

Authors:  J Takala
Journal:  Intensive Care Med       Date:  1994-07       Impact factor: 17.440

Review 8.  Fluid management for the prevention and attenuation of acute kidney injury.

Authors:  John R Prowle; Christopher J Kirwan; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2013-11-12       Impact factor: 28.314

9.  Effect of cardiopulmonary bypass on lactate metabolism.

Authors:  Iqbal Mustafa; Hubert Roth; Asikin Hanafiah; Tarmizi Hakim; Maizul Anwar; Erwin Siregar; Xavier M Leverve
Journal:  Intensive Care Med       Date:  2003-07-05       Impact factor: 17.440

10.  Effects of norepinephrine alone and norepinephrine plus dopamine on human intestinal mucosal perfusion.

Authors:  Andreas Nygren; Anders Thorén; Sven-Erik Ricksten
Journal:  Intensive Care Med       Date:  2003-07-15       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.